Use of ionic matrices for maldi mass spectrometry analysis of tissue sections
The invention concerns improved methods for studying peptides/proteins expression in a tissue section or for determining at least one compound, in particular a protein, expression map in a tissue section, using ionic MALDI matrices.
1. A method for studying protein expression in a tissue section, comprising:
1) applying an ionic MALDI matrix onto the tissue section, wherein said ionic matrix is solid at room temperature and selected from the group consisting of [CHCA − ANI + ], [CHCA − DANI + ], [CHCA − 2A4M5NP + ], [CHCA − 3APY + ], [CHCA − PDA + ], [SA − ANI + ], [SA − DANI + ], [SA − DIENI + ], [SA − Et3NH + ], [SA − PIP + ], [SA − 3AQ + ], and [SA − 3APY + ];
2) scanning the tissue section with a MALDI mass spectrometer and saving the resulting data, and
3) in each analyzed point, determining the protein composition by comparing the obtained spectrum with database proteins molecular weights and spectra.
2. A method for determining at least one-peptide or protein expression map in a tissue section, comprising:
1) applying an ionic MALDI matrix on the tissue section, wherein said ionic matrix is solid at room temperature and selected from the group consisting of [CHCA − ANI + ], [CHCA − DANI + ], [CHCA − 2A4M5NP + ], [CHCA − 3APY + ], [CHCA − PDA + ], [SA − ANI + ], [SA − DANI + ], [SA − DIENI + ], [SA − Et3NH + ], [SA − PIP + ], [SA − 3AQ + ], and [SA − 3APY + ];
2) scanning the tissue section with an MALDI mass spectrometer and saving the resulting data, and
3) analyzing the obtained data in the molecular mass window(s) of each distinct peptide or protein to create as many maps of peptide or protein expression in the tissue section as the number of distinct studied peptide(s) or protein(s).
3. The method of claim 1 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − ANI + ], [CHCA − DANI + ], and [CHCA − 2A4M5NP + ].
4. The method of claim 1 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − 3Apy + ] and [CHCA − PDA + ].
5. The method of claim 2 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − ANI + ], [CHCA − DANI + ], and [CHCA − 2A4M5NP + ].
6. The method of claim 2 , wherein said ionic MALDI matrix is selected from [CHCA − 3Apy + ] and [CHCA − PDA + ].
7. An ionic matrix that is solid at room temperature and selected from the group consisting of [CHCA − DANI + ], [CHCA − 2A4M5NP + ], [SA − ANI + ], [SA − DANI + ], [SA − PIP + ], [SA − 3AQ + ], [SA − 2A4M5NP + ], [CHCA − 3Apy + ], [CHCA + PDA + ], and [SA − 3APY + ].
8. The method of claim 1 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − DANI + ], [CHCA − 2A4M5NP + ], [CHCA − 3APY + ], [CHCA − PDA + ], [SA − ANI + ], [SA − DANI + ], [SA − PIP + ], [SA − 3AQ + ], and [SA − 3APY + ].
9. The method of claim 2 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − DANI + ], [CHCA − 2A4M5NP + ], [CHCA − 3APY + ], [CHCA − PDA + ], [SA − ANI + ], [SA − DANI + ], [SA − PIP + ], [SA − 3AQ + ], and [SA − 3APY + ].
10. The method of claim 3 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − DANI + ], and [CHCA − 2A4M5NP + ].
11. The method of claim 5 , wherein said ionic MALDI matrix is selected from the group consisting of [CHCA − DANI + ], and [CHCA − 2A4M5NP + ].